Litcius/Paper detail

Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway

Hiroaki Ihara, Yoichiro Mitsuishi, Motoyasu Kato, Fumiyuki Takahashi, Ken Tajima, Takuo Hayashi, Moulid Hidayat, Wira Winardi, Aditya Wirawan, Daisuke Hayakawa, Koichiro Kanamori, N Matsumoto, Toshifumi Yae, Tadashi Sato, Shin‐ichi Sasaki, Kazuya Takamochi, Yoshiyuki Suehara, Dai Ogura, Shin‐ichiro Niwa, Kenji Suzuki, Kazuhisa Takahashi

2020Respiratory Investigation46 citationsDOI

Topics & Concepts

MedicineNintedanibSMADA549 cellEpithelial–mesenchymal transitionCell biologyTransforming growth factorInternal medicineLungIdiopathic pulmonary fibrosisBiologyMetastasisCancerInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisLung Cancer Treatments and MutationsLung Cancer Diagnosis and Treatment
Nintedanib inhibits epithelial-mesenchymal transition in A549 alveolar epithelial cells through regulation of the TGF-β/Smad pathway | Litcius